These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8320323)

  • 1. Abnormal growth factor and cytokine expression in Dupuytren's contracture.
    Baird KS; Crossan JF; Ralston SH
    J Clin Pathol; 1993 May; 46(5):425-8. PubMed ID: 8320323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
    Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M
    Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of platelet-derived growth-factor gene in Dupuytren contracture.
    Terek RM; Jiranek WA; Goldberg MJ; Wolfe HJ; Alman BA
    J Bone Joint Surg Am; 1995 Jan; 77(1):1-9. PubMed ID: 7822340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique microRNA profile in Dupuytren's contracture supports deregulation of β-catenin pathway.
    Mosakhani N; Guled M; Lahti L; Borze I; Forsman M; Pääkkönen V; Ryhänen J; Knuutila S
    Mod Pathol; 2010 Nov; 23(11):1544-52. PubMed ID: 20676061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dupuytren's contracture: an update of biomolecular aspects and therapeutic perspectives.
    Cordova A; Tripoli M; Corradino B; Napoli P; Moschella F
    J Hand Surg Br; 2005 Dec; 30(6):557-62. PubMed ID: 16168532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's disease.
    Bayat A; Watson JS; Stanley JK; Alansari A; Shah M; Ferguson MW; Ollier WE
    J Bone Joint Surg Br; 2002 Mar; 84(2):211-5. PubMed ID: 11924651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic susceptibility in Dupuytren's disease: lack of association of a novel transforming growth factor beta(2) polymorphism in Dupuytren's disease.
    Bayat A; Alansar A; Hajeer AH; Shah M; Watson JS; Stanley JK; Ferguson MW; Ollier WE
    J Hand Surg Br; 2002 Feb; 27(1):47-9. PubMed ID: 11895345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta: possible roles in Dupuytren's contracture.
    Kloen P; Jennings CL; Gebhardt MC; Springfield DS; Mankin HJ
    J Hand Surg Am; 1995 Jan; 20(1):101-8. PubMed ID: 7722248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An insight into Dupuytren's contracture.
    Murrell GA
    Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fascia.
    Alioto RJ; Rosier RN; Burton RI; Puzas JE
    J Hand Surg Am; 1994 May; 19(3):442-52. PubMed ID: 8056971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The collagen changes of Dupuytren's contracture.
    Murrell GA; Francis MJ; Bromley L
    J Hand Surg Br; 1991 Aug; 16(3):263-6. PubMed ID: 1960490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis of Dupuytren's contracture--a review].
    Koźma EM; Olczyk K; Bobiński R; Kasperczyk M; Szpyra K
    Chir Narzadow Ruchu Ortop Pol; 2002; 67(1):73-9. PubMed ID: 12087679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
    Qian A; Meals RA; Rajfer J; Gonzalez-Cadavid NF
    Urology; 2004 Aug; 64(2):399-404. PubMed ID: 15302515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease.
    Riester SM; Arsoy D; Camilleri ET; Dudakovic A; Paradise CR; Evans JM; Torres-Mora J; Rizzo M; Kloen P; Julio MK; van Wijnen AJ; Kakar S
    BMC Med Genomics; 2015 Oct; 8():59. PubMed ID: 26446724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free radicals and Dupuytren's contracture.
    Murrell GA; Francis MJ; Bromley L
    Br Med J (Clin Res Ed); 1987 Nov; 295(6610):1373-5. PubMed ID: 2825907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression analysis of Dupuytren's disease: the role of TGF-beta2.
    Zhang AY; Fong KD; Pham H; Nacamuli RP; Longaker MT; Chang J
    J Hand Surg Eur Vol; 2008 Dec; 33(6):783-90. PubMed ID: 18694919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of growth factors, cytokines and matrix metalloproteinases in frozen shoulder.
    Bunker TD; Reilly J; Baird KS; Hamblen DL
    J Bone Joint Surg Br; 2000 Jul; 82(5):768-73. PubMed ID: 10963182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
    Ulrich D; Ulrich F; Piatkowski A; Pallua N
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.